site stats

Epiendo pharmaceuticals events

WebNov 14, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on enhancement of epithelial barrier integrity as a critical pathophysiological... WebMar 24, 2024 · REYKJAVIK, Iceland--(BUSINESS WIRE)-- EpiEndo Pharmaceuticals is pleased to announce the appointment of Stefan Petursson as Chief Financial Officer (CFO), starting 1 April 2024.EpiEndo Pharmaceuticals is a privately held biopharmaceutical company developing a therapeutic pipeline for the treatment of inflammatory disorders …

EpiEndo Pharmaceuticals wins the Swedish American Life ... - BioSpace

WebHome EpiEndo Pharmaceuticals A NOVEL APPROACH TO AIRWAY DISEASES Find out more about our unique therapeutic strategy Our non-antibiotic macrolide platform … Welcome to EpiEndo Pharmaceuticals. EpiEndo is a clinical stage … EpiEndo's compounds enhance the epithelial barrier, appearing to … EpiEndo’s lead compounds are analogues of azithromycin, specifically designed to … OUR NEWS & EVENTS. Feb 15; Dr Kate Hanrott appointed as Director of Clinical … WebAug 18, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on enhancement of epithelial barrier … soho homes new york https://collectivetwo.com

EpiEndo Pharmaceuticals Expands its Leadership Team, …

WebNov 15, 2024 · Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News! WebJun 29, 2024 · In August 2024, EpiEndo Pharmaceuticals announced the closing of a €20m Series A financing round led by Flerie Invest and Iðunn Venture Fund, with existing investors ABC Ventures participating,... WebApr 13, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier … slq camp humphreys

EpiEndo Pharmaceuticals wins the SALSS Rising Star Award

Category:EpiEndo Pharmaceuticals Announces Launch of First-in-Human …

Tags:Epiendo pharmaceuticals events

Epiendo pharmaceuticals events

EpiEndo Pharmaceuticals wins the SALSS Rising Star Award

WebOct 25, 2024 · REYKJAVIK, Iceland--(BUSINESS WIRE)-- EpiEndo Pharmaceuticals (www.epiendo.com) is pleased to announce that it is the recipient of this year’s Rising Star Award at the Swedish American Life Sciences Summit (SALSS).EpiEndo is a privately held biopharmaceutical company focused on a novel barrier enhancing approach to the … WebAug 31, 2024 · EpiEndo Pharmaceuticals: Maria Bech, CEO Email: [email protected] Tel: +354 454 0090 Instinctif Partners (media relations): Rozi Morris / Katie Duffell Email: [email protected] Tel: +44 ...

Epiendo pharmaceuticals events

Did you know?

WebPhone Number 00 354 454 0090. EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of … WebApr 13, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier integrity as a causal pathophysiological factor underlying the etiology of …

WebOct 25, 2024 · REYKJAVIK, ICELAND – 25 October 2024 – EpiEndo Pharmaceuticals (www.epiendo.com) is pleased to announce that it is the recipient of this year’s Rising Star Award at the Swedish American Life Science Summit (SALSS). EpiEndo is a privately held biopharmaceutical company focused on a novel barrier enhancing approach to the … WebPhone Number 00 354 454 0090 EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier integrity as a causal pathophysiological factor underlying the etiology of a number of major diseases.

WebOct 23, 2024 · EpiEndo is developing a candidate drug with a novel mode of action that, if successfully brought to the patients, could change the treatment paradigm for COPD,” said Eugen Steiner, member of the award jury. “EpiEndo won the top scores from all judges in the criteria of innovation and impact, giving it the lead over competitors. WebFeb 24, 2024 · EpiEndo’s lead drug candidate, EP395, aims to be the first on-market oral, disease modifying, non-antibiotic, barrier strengthening and anti-inflammatory macrolide for COPD. For more information ...

WebApr 6, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier integrity as a causal pathophysiological factor underlying the etiology of …

WebOct 25, 2024 · EpiEndo Pharmaceuticals wins the Swedish American Life Sciences Summit (SALSS) Rising Star Award 2024. Maria Bech, CEO and Dr Fridrik Gardarsson, … soho hotel breakfast menuWebAug 18, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on enhancement of epithelial barrier integrity as a critical pathophysiological factor underlying the etiology of … soho hotel mothers dayWebEpiEndo Pharmaceuticals Raises €800,000 to Advance Breakthrough Treatments for Respiratory Diseases EpiEndo is pleased to announce that we have successfully closed … slq top